Coldstream Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.64M Buy
21,717
+5,045
+30% +$1.8M 0.09% 114
2025
Q4
$5.46M Sell
16,672
-760
-4% -$241K 0.07% 146
2025
Q3
$4.92M Sell
17,432
-2,441
-12% -$708K 0.07% 150
2025
Q2
$5.55M Buy
19,873
+1,985
+11% +$562K 0.09% 128
2025
Q1
$5.57M Buy
17,888
+1,416
+9% +$418K 0.12% 110
2024
Q4
$4.29M Sell
16,472
-12,174
-42% -$3.61M 0.09% 137
2024
Q3
$9.22M Buy
28,646
+710
+3% +$232K 0.2% 71
2024
Q2
$8.73M Buy
27,936
+1,216
+5% +$357K 0.21% 66
2024
Q1
$7.6M Buy
26,720
+215
+0.8% +$62.9K 0.19% 76
2023
Q4
$7.63M Buy
26,505
+11,839
+81% +$3.23M 0.21% 64
2023
Q3
$3.94M Buy
14,666
+4,424
+43% +$1.1M 0.13% 111
2023
Q2
$2.27M Sell
10,242
-241
-2% -$55.9K 0.07% 154
2023
Q1
$2.53M Sell
10,483
-250
-2% -$61.4K 0.09% 145
2022
Q4
$2.82M Buy
+10,733
New +$2.88M 0.1% 131
2022
Q2
$3.78M Buy
15,531
+1,439
+10% +$353K 0.15% 107
2022
Q1
$3.41M Buy
14,092
+1,465
+12% +$337K 0.12% 111
2021
Q4
$2.84M Sell
12,627
-6,577
-34% -$1.39M 0.09% 143
2021
Q3
$4.88M Buy
19,204
+13,870
+260% +$3.19M 0.24% 59
2021
Q2
$1.3M Buy
5,334
+483
+10% +$119K 0.05% 195
2021
Q1
$1.21M Sell
4,851
-13,195
-73% -$3.15M 0.07% 160
2020
Q4
$4.15M Buy
18,046
+1,097
+6% +$253K 0.25% 60
2020
Q3
$4.31M Buy
16,949
+102
+0.6% +$25.3K 0.36% 40
2020
Q2
$3.97M Sell
16,847
-1,442
-8% -$329K 0.36% 42
2020
Q1
$3.71M Sell
18,289
-981
-5% -$214K 0.41% 36
2019
Q4
$4.64M Buy
19,270
+195
+1% +$43K 0.38% 41
2019
Q3
$3.69M Buy
19,075
+698
+4% +$134K 0.31% 58
2019
Q2
$3.39M Sell
18,377
-153
-0.8% -$27.4K 0.28% 66
2019
Q1
$3.52M Buy
18,530
+1,227
+7% +$234K 0.31% 62
2018
Q4
$3.37M Buy
17,303
+427
+3% +$83.3K 0.33% 62
2018
Q3
$3.5M Buy
16,876
+723
+4% +$142K 0.32% 57
2018
Q2
$2.98M Buy
16,153
+293
+2% +$51.8K 0.3% 62
2018
Q1
$2.7M Sell
15,860
-587
-4% -$108K 0.29% 65
2017
Q4
$2.86M Buy
16,447
+519
+3% +$91.8K 0.31% 68
2017
Q3
$2.97M Buy
15,928
+970
+6% +$172K 0.35% 62
2017
Q2
$2.58M Buy
14,958
+1,457
+11% +$237K 0.33% 59
2017
Q1
$2.21M Buy
13,501
+154
+1% +$25.6K 0.31% 62
2016
Q4
$1.95M Buy
13,347
+1,004
+8% +$151K 0.32% 66
2016
Q3
$2.06M Sell
12,343
-789
-6% -$133K 0.36% 46
2016
Q2
$2M Sell
13,132
-32
-0.2% -$4.97K 0.35% 51
2016
Q1
$1.97M Sell
13,164
-376
-3% -$55.9K 0.36% 46
2015
Q4
$2.2M Buy
13,540
+888
+7% +$140K 0.48% 32
2015
Q3
$1.75M Buy
+12,652
New +$1.99M 0.47% 56

Other funds holding AMGN

Coldstream Capital Management's AMGN Position: Q1 2026 in Review

Coldstream Capital Management increased its Amgen (AMGN) stake by 30% in Q1 2026, buying an estimated $1.8M and bringing the position to 21,717 shares worth $7.64M. The position accounts for 0.09% of the portfolio, ranked #114.

Coldstream Capital Management first reported a position in AMGN in Q3 2015 and has held it in 42 quarters since. The position peaked at $9.22M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Coldstream Capital Management held 21,717 shares of Amgen worth $7.64M as of Q1 2026.
  • Coldstream Capital Management bought 5,045 Amgen shares in Q1 2026, an estimated $1.8M.
  • Amgen made up 0.09% of Coldstream Capital Management's portfolio in Q1 2026, its #114 holding.
  • Coldstream Capital Management first reported a position in Amgen in Q3 2015 and has held it in 42 quarters since.
  • Coldstream Capital Management's Amgen position peaked at $9.22M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.